Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Patient Preferences Regarding Anticoagulation Therapy in Patients with Cancer Having a VTE Event - a Discrete Choice Experiment in the Cosimo Study

Nils Picker, MSc, Alexander T Cohen, MBBS, MSc, MD, Anthony Maraveyas, MD PhD, Jan Beyer-Westendorf, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC, Lorenzo G Mantovani, Yoriko De Sanctis, MS, Khaled Abdelgawwad, Samuel Fatoba, Miriam Bach, Thomas Wilke, Prof. Dr. rer. oec.

Blood (2019) 134 (Supplement_1): 2159.

https://doi.org/10.1182/blood-2019-128095

Published: 2019

Journal Articles

Baseline Characteristics and Clinical Outcomes from the Cancer Associated Thrombosis - Patient Reported Outcomes with Rivaroxaban (COSIMO) Trial

Anthony Maraveyas, MD PhD, Jan Beyer-Westendorf, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC, Lorenzo G Mantovani, Yoriko De Sanctis, MS, Khaled Abdelgawwad, Samuel Fatoba, Miriam Bach, Alexander T Cohen, MBBS, MSc, MD

Blood (2019) 134 (Supplement_1): 2161.

https://doi.org/10.1182/blood-2019-126810

Published: 2019

Journal Articles

Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies

Alex C. Spyropoulos, MD, Concetta Lipardi, MD PhD, Alexander T Cohen, MBBS, MSc, MD, Biljana Vučković, MD PhD, Jianfeng Xu, PhD, Wentao Lu, PhD, Theodore E. Spiro, MD, Elliot S. Barnathan, MD, Gary E. Raskob, PhD

Blood (2019) 134 (Supplement_1): 3671.

https://doi.org/10.1182/blood-2019-122945

Published: 2019

Journal Articles

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Alex C. Spyropoulos, MD, Gary E. Raskob, PhD, Alexander T Cohen, MBBS, MSc, MD, Walter Ageno, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Concetta Lipardi, MD PhD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 2441.

https://doi.org/10.1182/blood-2019-122930

Published: 2019

Journal Articles

Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study

Gary E. Raskob, PhD, Alex C. Spyropoulos, MD, Alexander T Cohen, MBBS, MSc, MD, Jeffrey I. Weitz, MD, Walter Ageno, Yoriko De Sanctis, MS, Wentao Lu, PhD, Jianfeng Xu, PhD, John Albanese, BS, MBA, Chiara Sugarmann, BSN, MSHS, Concetta Lipardi, MD PhD, Theodore E. Spiro, MD, Elliot S. Barnathan, MD

Blood (2019) 134 (Supplement_1): 163.

https://doi.org/10.1182/blood-2019-122934

Published: 2019

Journal Articles

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Alexander T Cohen, MBBS, MSc, MD, Allison Keshishian, Theodore Lee, MD, Gail Wygant, RN, MS, Lisa Rosenblatt, MD MPH, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Daniel Wiederkehr, MPH, Janvi Sah, MS, Xuemei Luo, PhD

Blood (2019) 134 (Supplement_1): 326.

https://doi.org/10.1182/blood-2019-121769

Published: 2019

Journal Articles

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale

Blood (2019) 134 (Supplement_1): 327.

https://doi.org/10.1182/blood-2019-126931

Published: 2019

Journal Articles

Infectious Complications Associated with CAR T-Cell Therapy

Lekha Mikkilineni, MD, Shilpa Shahani, MD, Bonnie Yates, NP, Seth M. Steinberg, PhD, Tara Palmore, MD, Veronique Nussenblatt, MD, Daniel W. Lee, MD, Rosandra N. Kaplan, MD, Crystal L. Mackall, MD, Terry J. Fry, MD, Juan Gea-Banacloche, MD, Theresa Jerussi, James N. Kochenderfer, MD, Nirali N. Shah, MD

Blood (2019) 134 (Supplement_1): 4449.

https://doi.org/10.1182/blood-2019-131170

Published: 2019

Journal Articles

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Jeffrey I. Weitz, MD, Gary E. Raskob, PhD, Alex C. Spyropoulos, MD, Alexander T Cohen, MD, Theodore E. Spiro, MD, Yoriko De Sanctis, MS, Jianfeng Xu, PhD, Eunyoung Suh, PhD, Wentao Lu, PhD, Concetta Lipardi, MDPhD, Elliot S. Barnathan, MD

Blood (2018) 132 (Supplement 1): 1236.

https://doi.org/10.1182/blood-2018-99-111911

Published: 2018

Journal Articles

Preclinical Anti-Lymphoma Activity of the BCL-2 BH4 Domain Antagonist Bda-366 in Mantle Cell Lymphoma

Sho Okamoto, MD, Aya Maeda, Shinya Kimura, MD, PhD, Kensuke Kojima, MD PhD

Blood (2017) 130 (Supplement 1): 3847.

https://doi.org/10.1182/blood.V130.Suppl_1.3847.3847

Published: 2017

Journal Articles

Combination of Adoptive Cellular Immunotherapy and Bortezomib-Based Regimens Increase the Progression Free Survival of the Patients with Multiple Myeloma

Jiuwei Cui, Wei Li, MD, Lei Qian, Chunshui Liu, Haofan Jin, Ou Bai, Yanqiu Song, Chao Niu, Dan Li, Huimin Tian, Wei Han, Hua He, Wei Song

Blood (2014) 124 (21): 2143.

https://doi.org/10.1182/blood.V124.21.2143.2143

Published: 2014

Journal Articles

Iron Restriction Via PKC Signaling Critically Contributes to Erythroid PU.1 Dysregulation in Anemia of Chronic Inflammation

Chante Richardson, M.S., Lorrie L. Delehanty, Adam Goldfarb, MD

Blood (2012) 120 (21): 3451.

https://doi.org/10.1182/blood.V120.21.3451.3451

Published: 2012

Journal Articles

Evaluation of Transcranial Doppler in 1135 Sickle Cell Disease Children From Brazil: What Is the Time Averaged Maximum Velocity for High Risk of Stroke Among HbSC Patients?

Camilo Vieira, MD, Isa Lyra, PhD, Marilda Goncalves, PhD

Blood (2012) 120 (21): 1003.

https://doi.org/10.1182/blood.V120.21.1003.1003

Published: 2012

Journal Articles

Manipulating the Erythroid Iron Deprivation Response Affects Inflammatory Signaling in Anemia of Chronic Inflammation

Chanté L. Richardson, Grant C. Bullock, MD, PhD, Lorrie L. Delehanty, Claudia Rival, Kenneth Tung, Adam Goldfarb

Blood (2011) 118 (21): 179.

https://doi.org/10.1182/blood.V118.21.179.179

Published: 2011

Journal Articles

Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats

Igor Theurl, Andrea Schroll, Thomas Sonnweber, Manfred Nairz, Milan Theurl, Wolfgang Willenbacher, Kathrin Eller, Dominik Wolf, Markus Seifert, Chia Chi Sun, Jodie L. Babitt, Charles C. Hong, Tracey Menhall, Patrick Gearing, Herbert Y. Lin, Guenter Weiss

Blood (2011) 118 (18): 4977–4984.

https://doi.org/10.1182/blood-2011-03-345066

Published: 2011

Includes: Supplemental data

Journal Articles

Innovative blood vessels bring new life

Edward K. Geissler, Peter Angele

Blood (2011) 118 (3): 488–490.

https://doi.org/10.1182/blood-2011-05-352609

Published: 2011

Journal Articles

Targeting the Erythroid Iron Deprivation Response as a Therapeutic Approach In Anemia Not Caused by Iron Deficiency

Chanté L. Richardson, Grant C. Bullock, Lorrie L. Delehanty, Adam N. Goldfarb

Blood (2010) 116 (21): 166.

https://doi.org/10.1182/blood.V116.21.166.166

Published: 2010

Journal Articles

Genetically Reengineered K562 Cells Significantly Expand Cord Blood (CB) Natural Killer (NK) Cells Ex-Vivo Expanded with Increased NK Cell Activation and Cytolytic Activity Both In-Vitro and In-Vivo: Potential Use In Adoptive Cellular Immunotherapy (ACI)

Michele Levin, MD, Janet Ayello, MS, MT(ASCP), Frances Zhao, MS, Andrew Stier, Lauren Tiffen, William Quish, Carmella vandeVen, MA, Laxmi V. Baxi, MD, Jessica Hochberg, MD, Mitchell S. Cairo, MD

Blood (2010) 116 (21): 3928.

https://doi.org/10.1182/blood.V116.21.3928.3928

Published: 2010

Journal Articles

To be old is to be inflamed?

Stanley L. Schrier

Blood (2010) 115 (18): 3651–3652.

https://doi.org/10.1182/blood-2010-02-267294

Published: 2010

Journal Articles

Significant Ex-Vivo Expansion and Functional Activation of Cord Blood (CB) Natural Killer (NK) Cells with A Concomittant Significant Decrease in CB T Cells Following Stimulation with Genetically Engineered K562 Cells (K562-mb15-41BBL).

Jessica Hochberg, MD, Janet Ayello, MS, MT, Carmella VandeVen, MS, Jeremy Gold, Evan Cairo, Frances Zhao, Mitchell S. Cairo, MD

Blood (2009) 114 (22): 499.

https://doi.org/10.1182/blood.V114.22.499.499

Published: 2009

NARROW

Patient Preferences Regarding Anticoagulation Therapy in Patients with Cancer Having a VTE Event - a Discrete Choice Experiment in the Cosimo Study

Baseline Characteristics and Clinical Outcomes from the Cancer Associated Thrombosis - Patient Reported Outcomes with Rivaroxaban (COSIMO) Trial

Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies

Association of Bleeding Severity with Mortality with in-Hospital and Extended Thromboprophylaxis in the Medically Ill in the Magellan Trial

Increased Risk of Death in Acutely Ill Medical Patients with Asymptomatic Proximal Deep Vein Thrombosis or Symptomatic Venous Thromboembolism: Insights from the Magellan Study

Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases

Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale

Infectious Complications Associated with CAR T-Cell Therapy

Medically Ill Patients with Moderate Renal Insufficiency Have More Thrombotic and Bleeding Events Than Those with Normal Renal Function: Insights from the Magellan and Mariner Trials of Extended Thrombprophylaxis

Preclinical Anti-Lymphoma Activity of the BCL-2 BH4 Domain Antagonist Bda-366 in Mantle Cell Lymphoma

Combination of Adoptive Cellular Immunotherapy and Bortezomib-Based Regimens Increase the Progression Free Survival of the Patients with Multiple Myeloma

Iron Restriction Via PKC Signaling Critically Contributes to Erythroid PU.1 Dysregulation in Anemia of Chronic Inflammation

Evaluation of Transcranial Doppler in 1135 Sickle Cell Disease Children From Brazil: What Is the Time Averaged Maximum Velocity for High Risk of Stroke Among HbSC Patients?

Manipulating the Erythroid Iron Deprivation Response Affects Inflammatory Signaling in Anemia of Chronic Inflammation

Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats

Innovative blood vessels bring new life

Targeting the Erythroid Iron Deprivation Response as a Therapeutic Approach In Anemia Not Caused by Iron Deficiency

Genetically Reengineered K562 Cells Significantly Expand Cord Blood (CB) Natural Killer (NK) Cells Ex-Vivo Expanded with Increased NK Cell Activation and Cytolytic Activity Both In-Vitro and In-Vivo: Potential Use In Adoptive Cellular Immunotherapy (ACI)

To be old is to be inflamed?

Significant Ex-Vivo Expansion and Functional Activation of Cord Blood (CB) Natural Killer (NK) Cells with A Concomittant Significant Decrease in CB T Cells Following Stimulation with Genetically Engineered K562 Cells (K562-mb15-41BBL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only